Username Password
S&P 500: 1,913.85
Change: -2.96%

UNITED THERAPEUTICS CORPORATION (UTHR)

Overview
Price 144.61
Price Change Today -$6.01 (-3.99%)
P&P rating Rating: 3
Open Price $148.43
Previous Close $150.62
Daily Range $144.09 - $153.45
52-Week Range $110.12 - $190.29
Volume 1
chart
Top Buy Analysis
BUY: UTHR Rating: 3
Company: UNITED THERAPEUTICS CORPORATION
Points: 58.19
Start Price: $93.75
Start Date: 08/21/2014 1:11 AM
wrbeeler
wrbeeler
P&P Score: 0.60
Recs:
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Top Sell Analysis
SELL: UTHR Rating: 3
Company: UNITED THERAPEUTICS CORPORATION
Points: -8.77
Start Price: $103.93
Start Date: 01/01/2008 12:00 AM
sal23
sal23
P&P Score: 38.95
Recs:

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

14 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 02/16/10 Zantrio.com Free Daily Stock Picks 2-16-2010 0
Zacks_Analysts
0.00 02/11/13 Warner Chilcott Provides 2013 View - Analyst Blog 0
Zacks_Analysts
0.00 02/11/13 Warner Chilcott Provides 2013 View - Analyst Blog 0
Zacks_Analysts
0.00 02/06/13 Pipeline Progess at ArQule - Analyst Blog 0
Zacks_Analysts
0.00 02/06/13 Pipeline Progess at ArQule - Analyst Blog 0
Zacks_Analysts
0.00 01/31/13 Pluristem Moves to New Facility - Analyst Blog 0
Zacks_Analysts
0.00 01/31/13 Pluristem Moves to New Facility - Analyst Blog 0
Zacks_Analysts
0.00 01/16/13 Pluristem Study to Expand to Germany - Analyst Blog 0
Zacks_Analysts
0.00 01/16/13 Pluristem Study to Expand to Germany - Analyst Blog 0
Zacks_Analysts
0.00 01/04/13 Pluristem Progresses with New Facility - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6  >>
Commentary
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +58.19
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +48.60
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +48.45
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +58.19
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +48.60
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $93.75
Points: +48.45
Created: 08/21/2014
THIS COMPANY HAS SEVERAL PHARMS. THAT ARE IN STAGE 2 OR STAGE 3 THAT ARE ALREADY MAKING A LOT OF INCOME. THE STOCK HAS A VERY LOW PE & PEG OF .66. HAS AN ROE OF 23.47 AND NO DEBT. IT HAS A HEALTHY MARGIN OF 24.42.

Comments: 0 | Comment

Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $49.82
Points: +148.19
Created: 02/07/2012

Comments: 0 | Comment

vip vip
Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $49.82
Points: +134.00
Created: 02/07/2012

Comments: 0 | Comment

vip vip
Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $49.82
Points: +133.78
Created: 02/07/2012

Comments: 0 | Comment

vip vip
Recs:
 
BUY: UNITED THERAPEUTICS CORPORATION (UTHR) Rating: 3
Start Price: $49.82
Points: +148.19
Created: 02/07/2012

Comments: 0 | Comment

vip vip
Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% -3.94% +58.19 view
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% +5.65% +48.60 view
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% +5.80% +48.45 view
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% -3.94% +58.19 view
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% +5.65% +48.60 view
wrbeeler 0.60 BUY One to Three Years 08/21/2014 $93.75 $144.61
(-3.99%)
+54.25% +5.80% +48.45 view
vip 52.81 BUY One to Three Months 02/07/2012 $49.82 $144.61
(-3.99%)
+190.26% +42.08% +148.19
vip 52.81 BUY One to Three Months 02/07/2012 $49.82 $144.61
(-3.99%)
+190.26% +56.27% +134.00
vip 52.81 BUY One to Three Months 02/07/2012 $49.82 $144.61
(-3.99%)
+190.26% +56.49% +133.78
vip 52.81 BUY One to Three Months 02/07/2012 $49.82 $144.61
(-3.99%)
+190.26% +42.08% +148.19
Pages: [ 1 ]  2  >>
Sponsored Links